Had pretty much decided I was done with posting on this Forum.
But, I do believe that some of these ongoing developments are interesting enough for me to forgo that in some instances.
So I will do so to add whatever I run across that is of interest here:
Antisense, RNAi And MicroRNA Explained
Make Way For RNA Based Therapies
The up hill battle of RNA therapeutics to the clinic continues despite extensive use in research. Recall from high school biology that RNA translates DNA code into a language ribosomes can understand in order to make proteins required by the cell.
Fighting the good fight are antisense, RNAi, and microRNA. With their high specificity and relative low manufacturing cost, these technologies may be tomorrow’s biotech sweetheart. In fact, chances are good that previously “undruggable” targets (that cannot be accessed by small or large molecule drugs) are within arm’s reach. However, the main hurdle continues to be delivery—getting the RNA drug where it needs to be, in high enough concentrations, to be effective.
This WEEKLY examines the similarities and differences between the RNA therapeutics winding their way through the clinic and into the marketplace.
Discover how RNA-based drug therapy provides personalized patient solutions & targets 'undruggable' areas, with Antisense, RNAi, & MicroRNA.
weekly.biotechprimer.com